Paxalisib in DPG - I did not clarify in that post from 20 minutes ago.
-------------------------------------
Also worth putting this up below, also - it certainly is current information.
Its shows the scale of success or otherwise - of cancer drug development.
Needless to say, for any new readers here - Kazia has clinical trials underway for lung cancers that have moved to the brain. Lung cancer in the brain - extremely likely for paxalisib to work outside of the CNS also. But anyway - I am just presenting here more of the same stuff........................
There are 100 research papers on google which explains that many cancers escape through these errant PI3K pathways. Paxalisib is a drug that repairs these damaged pathway, so as to work in combination with "household" name type cancer drug.
But no 14 billion here, that is for sure - maybe the odd 1 or 2 cent pip increase in SP, can appeal to investors, becoming a little desensitized to disappointment here. ---------------------
July 2023
AstraZeneca stock value falls by nearly £14bn after cancer drug trial results
Shares close down 8% on concerns that new lung cancer drug may not be as successful as hoped
Nearly £14bn has been wiped off the stock market value of AstraZeneca over concerns that a new lung cancer drug may not be as successful as had been hoped.
KZA Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
